Clinical Trials
4 trialsNCT07469774 2026-05-28
BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Biocity Biopharmaceutics Co., Ltd.
Phase 1/2 Recruiting
NCT05830539 2025-05-02
IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients
InxMed (Shanghai) Co., Ltd.
Phase 1/2 Completed
NCT06244992 2025-03-12
PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors
Pyrotech Therapeutics, Inc.
Phase 1/2 Recruiting
NCT06293651 2025-02-12
Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
Dong-A ST Co., Ltd.
Phase 1/2 Recruiting